SFSina Frischholz

Sina Frischholz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sina Frischholz has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Bernd Spriewald

    Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen; Erlangen, Germany

    2 shared publications
  • Kilian Schober

    Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany

    2 shared publications
  • Lucia Klotz

    Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany

    2 shared publications
  • Benjamin Schubert

    Institute for Computational Biology, Helmholtz Zentrum München

    1 shared publication
  • Christian Bogdan

    Mikrobiologisches Institut—Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany

    1 shared publication
  • Christine Schülein

    Mikrobiologisches Institut–Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    1 shared publication

Latest Publications

  • Open Access

    A pro-inflammatory effector-memory T cell program links peripheral EBV priming to CNS autoimmunity

    by Nikolaj Pagh Kristensen, Thanos Tsaktanis, Sina Frischholz, Jasim K. Benotmane, Lucia Klotz, Philipp Hilgendorf, Myriam Grotz, Mariana V. Sousa, Lasse F. Voss, Stefan Schattgen, et al.

    T and B cell–mediated immunosurveillance of the central nervous system (CNS) can become maladaptive in multiple sclerosis (MS). Epstein–Barr virus (EBV) is a likely driver of MS, yet how exactly EBV-specific T cells contribute remains unclear. We generated an antigen-resolved atlas of blood and cerebrospinal fluid (CSF) T cells from untreated MS patients and controls. T cell clones carrying a GZMK + effector-memory program in blood were CSF-biased, particularly in MS, and associated with EBV reactivity. In CSF, EBV-reactive GZMK + CD8 + T cells engaged B lineage cells. Activated CD8 + T cells promoted atypical B cell and plasmablast formation, whereas GZMK-enriched effector-memory cells induced IL-6 and IL-8 release from myeloid cells. Together, these findings identify an infection-imprinted, CNS-biased state and support a model in which EBV-specific CD8 + T cells contribute to inflammation through a non-canonical mode of B cell and myeloid cell activation. Abstract Figure:

  • Open Access

    Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory

    by Sina Frischholz, Ev-Marie Schuster, Myriam Grotz, Christine Schülein, Julia Benz, Katharina Kocher, Lucia Klotz, Szilard Varga, Theresa Hiltner, Rayya Alsalameh, et al.

    Metabolic activity shapes cell fate but remains challenging to capture in vivo with high resolution. Here we performed longitudinal metabolic and phenotypic profiling of human antigen-specific CD8 + T cells after yellow fever vaccination using flow cytometry and single-cell RNA sequencing. As assessed by protein translation rates, CD8 + T cells upregulated glycolysis to fuel anabolic needs for proliferation but predominantly used oxidative phosphorylation for energy production during the acute phase (days 7–28) after vaccination. Simultaneously, CD8 + CD62L + CD45RA − central memory T cells were the most metabolically active subset, whereas CD8 + CD62L − CD45RA + effector T cells underwent metabolic shutdown. Weakly differentiated CD8 + CD62L + CD45RA + CD95 − naive-like memory T cells showed minimal activity, relied solely on oxidative phosphorylation and were preferentially maintained 26 years postvaccination, reinforcing the link between cellular quiescence and longevity. Our study highlights quiescence as a key feature for long-term immunological memory formation in humans.